NYXOAH financials
NYXOAH
5493002O1ESKZ18OXR80 | Line item | 2023 | 2022 |
|---|---|---|
| Income statement | ||
| Cost of sales | €1.7M | €1.1M |
| Gross profit | €2.7M | €1.9M |
| Operating profit (EBIT) | -€45.1M | -€32.5M |
| Finance costs | €3.7M | €4.3M |
| Profit before tax | -€44.7M | -€30.1M |
| Income tax expense | -€1.4M | €1.2M |
| Profit for the year | -€43.2M | -€31.2M |
| — attributable to owners | -€43.2M | -€31.2M |
| Total comprehensive income | -€43.3M | -€31.3M |
| Per share | ||
| Basic EPS | €-1.54 | €-1.21 |
| Diluted EPS | €-1.54 | €-1.21 |
| Free cash flow / share | €-1.69 | €-1.15 |
| Cash flow statement | ||
| Cash generated from operations | -€44.0M | -€28.3M |
| Net cash from operating activities | -€44.8M | -€28.8M |
| Net cash from investing activities | €32.0M | -€89.9M |
| Purchase of PP&E (capex) | €2.5M | €886.0K |
| Purchase of intangibles | €8.5M | €15.5M |
| Net cash from financing activities | €16.9M | -€983.0K |
| Lease liability payments | €757.0K | €772.0K |
| Net change in cash | €4.1M | -€119.7M |
| Balance sheet | ||
| Total assets | €124.2M | €146.1M |
| Non-current assets | €55.8M | €45.8M |
| Property, plant & equipment | €4.2M | €2.5M |
| Right-of-use assets | €3.8M | €3.2M |
| Current assets | €68.4M | €100.3M |
| Inventories | €3.3M | €882.0K |
| Trade & other receivables | €2.8M | €1.5M |
| Cash & equivalents | €21.6M | €17.9M |
| — attributable to owners | €98.0M | €120.3M |
| Non-current liabilities | €11.7M | €10.8M |
| Lease liabilities (non-current) | €3.1M | €2.6M |
| Current liabilities | €14.4M | €14.9M |
| Lease liabilities (current) | €851.0K | €719.0K |
| Deferred tax liabilities | €9.0K | €0 |
| Derived metrics | ||
| Free cash flow | -€47.3M | -€29.6M |
| Return on equity | -44.1% | -26.0% |
| Cash conversion ratio | 1.04× | 0.92× |
| Capex coverage | -17.91× | -32.46× |
| Other reported items | ||
| Adjustments For Amortisation Expense | €962.0K | €813.0K |
| Adjustments For Decrease Increase In Inventories | -€2.4M | -€536.0K |
| Adjustments For Decrease Increase In Trade Account Receivable | -€1.5M | €7.0K |
| Adjustments For Depreciation Expense | €1.4M | €1.1M |
| Adjustments For Finance Costs | €3.7M | €4.3M |
| Adjustments For Finance Income | €4.2M | €6.8M |
| Adjustments For Increase Decrease In Trade Account Payable | €479.0K | €615.0K |
| Adjustments For Provisions | €216.0K | €37.0K |
| Adjustments For Sharebased Payments | €2.6M | €2.7M |
| Cash Flows From Used In Operations Before Changes In Working Capital | -€40.5M | -€28.4M |
| Comprehensive Income Attributable To Owners of Parent | -€43.3M | -€31.3M |
| Current Tax Liabilities Current | €2.0M | €3.7M |
| Deferred Tax Assets | €56.0K | €47.0K |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€369.0K | €2.1M |
| Equity and Liabilities | €124.2M | €146.1M |
| Finance Income | €4.2M | €6.8M |
| Gains Losses On Exchange Differences On Translation Net of Tax | -€120.0K | -€96.0K |
| General and Administrative Expense | €21.7M | €18.9M |
| Income Taxes Paid Refund Classified As Operating Activities | €789.0K | €410.0K |
| Intangible Assets Other Than Goodwill | €46.6M | €40.0M |
| Interest Paid Classified As Financing Activities | €192.0K | €130.0K |
| Interest Received Classified As Investing Activities | €2.3M | €110.0K |
| Interest Received Classified As Operating Activities | €0 | €3.0K |
| Issued Capital | €4.9M | €4.4M |
| Liabilities | €26.1M | €25.7M |
| Noncurrent Provisions | €185.0K | €59.0K |
| Noncurrent Receivables | €1.2M | €173.0K |
| Noncurrent Recognised Liabilities Defined Benefit Plan | €9.0K | €0 |
| Other Adjustments For Noncash Items | -€256.0K | -€356.0K |
| Other Comprehensive Income | -€39.0K | -€26.0K |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €81.0K | €70.0K |
| Other Current Assets | €1.3M | €1.3M |
| Other Current Financial Assets | €36.1M | €77.0M |
| Other Current Financial Liabilities | €364.0K | €388.0K |
| Other Current Payables | €5.1M | €5.2M |
| Other Inflows Outflows of Cash Classified As Financing Activities | -€51.0K | -€37.0K |
| Other Noncurrent Financial Liabilities | €8.4M | €8.2M |
| Other Operating Income Expense | €544.0K | €283.0K |
| Other Receivables | €3.2M | €1.8M |
| Other Reserves | €137.0K | €176.0K |
| Proceeds From Issuing Shares | €18.3M | €255.0K |
| Proceeds From Sales Or Maturity of Financial Instruments Classified As Investing Activities | €120.7M | €28.9M |
| Purchase of Financial Instruments Classified As Investing Activities | €80.0M | €102.6M |
| Research and Development Expense | €26.7M | €15.9M |
| Reserve of Sharebased Payments | €7.7M | €5.6M |
| Retained Earnings | -€160.8M | -€118.2M |
| Revenue From Sale of Goods | €4.3M | €3.1M |
| Share Premium | €246.1M | €228.3M |
| Trade and Other Payables To Trade Suppliers | €6.2M | €5.0M |
Every line item above is a fact tagged in NYXOAH's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.